🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess long term safety in participants who...
Status
Recruiting
Location
Providence Medical Foundation
Start Date
2020-12-22
Trial ID
NCT04638647
Treatments Being Tested
The core and extension studies assessed the safety and efficacy of secukinu...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-09
Trial ID
NCT01350804
This is a prospective, randomized, open-label, parallel-controlled clinical...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-15
Trial ID
NCT07704190
Treatments Being Tested
This study will assess the safety and efficacy of secukinumab compared to p...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-06
Trial ID
NCT01365455
Treatments Being Tested
This was an extension study of secukinumab prefilled syringes in subjects w...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-06-19
Trial ID
NCT01544595
Treatments Being Tested
The core and extension studies assessed the safety and efficacy of secukinu...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-08-30
Trial ID
NCT01377012
Treatments Being Tested
This 3-year extension study aims at making available the treatment with sec...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-11-06
Trial ID
NCT01863732
Treatments Being Tested
The goal of this observational study is to comprehensively profile six immu...
Status
Recruiting
Location
Radboud University Medical Center
Start Date
2025-07-29
Trial ID
NCT07021495
The investigators aim to compare the efficacy and safety of secukinumab and...
Status
Completed
Location
First Affiliated Hospital of Fujian Medical University
Start Date
2019-07-01
Trial ID
NCT06391996
This study will assess the efficacy and safety of secukinumab in patients w...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-10
Trial ID
NCT01358175
Treatments Being Tested